NCT06711315Completed
Oral Mucositis Management in Pediatric Oncology Patients
Oral Mucositis Management Supported by MASCC/ISOO Protocols: A Randomized Controlled Trial in Pediatric Oncology Patients
Source: ClinicalTrials.gov · Last updated 2 Dec 2024
Brief summary (registry, in English)
This study evaluated the impact of an oral mucositis care protocol on the severity of mucositis. The main questions it aims to answer are: -What is the severity of mucositis in parents and children who receive oral mucositis education? The data were collected using a descriptive information form, the Children's International Mucositis Evaluation Scale (ChIMES), and the WHO Oral Mucositis Grading Scale. Standard care was applied to the control group. For the intervention group, an oral care protocol was prepared, and the patients received training. The oral care intervention was applied for 14 days and monitored by the researcher. The patients were monitored for oral mucositis on Days 0, 3, 7, and 14. Those in the intervention group received a calendar for documenting their oral care practices.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 30 (actual)
- First submitted
- 26 Nov 2024
- Start date
- 1 Jun 2023
- Primary completion date
- 6 Aug 2024
- Lead sponsor
- Zubeyde Ezgi Ercelik
- Diseases
- Childhood cancers
- NCT number
- NCT06711315
What you commit to
- Study type: Interventional
- Participants enrolled: 30
- From 1 Jun 2023 to the primary completion date, 6 Aug 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- -Conditions that prevent verbal communication (neurodevelopmental delay, verbal speech difficulties, hearing or hearing problems; oral mucositis).
Who the study is looking for
- Being between 6 and 18 years,
- Having received at least 1 course of chemotherapy,
- Having no visual, auditory, or intellectual problems
- Speaking and understanding Turkish
- Being willing to participate in the research.
Age in the registry: 6 weeks to 18 weeks · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Zonguldak Bulent Ecevit University Training and Research Hospital Coordinator of this site? Confirm its status | Zonguldak | Turkey (Türkiye) | Unknown status |
Related publications
- Effectiveness of oral mucositis management based on MASCC/ISOO guidelines in pediatric oncology patients: a randomized controlled trial.Support Care Cancer · 2026 · PMID 41863643
This page is information, not medical advice. Discuss any trial with your doctor.